ESC 365 - GALACTIC-HF - omecamtiv mecarbil in HFrEF and low blood pressure

HFA Premium Access

GALACTIC-HF - omecamtiv mecarbil in HFrEF and low blood pressure

Session: Late-Breaking Trials - Pharmacological treatment I

Topic: Pharmacotherapy

Speaker: Professor M. Metra (Milan, IT)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Professor Marco Metra

IRCCS San Raffaele Scientific Institute, Milan (Italy)

148 presentations

50 followers

4 more presentations in this session

Patiromer for the management of hyperkalemia in subjects receiving renin-angiotensin-aldosterone system inhibitor medications for heart failure with reduced ejection fraction

Speaker: Professor S. Anker (Berlin, DE)

DEFINE-HF and PRESERVED-HF: Dapagliflozin improves heart failure symptoms and physical limitations across the entire range of LVEF

Speaker: Doctor M. Kosiborod (Kansas City, US)

DELIVER baseline and design

Speaker: Professor S. Solomon (Boston, US)

HELIOS-A: 18month Exploratory Cardiac Results from the Phase 3 Study of Vutrisiran in Patients with hATTR Amyloidosis

Speaker: Doctor P. Garcia-Pavia (Majadahonda, ES)

Access the full session

Late-Breaking Trials - Pharmacological treatment I

Speakers: Professor M. Metra, Professor S. Anker, Doctor M. Kosiborod, Professor S. Solomon, Doctor P. Garcia-Pavia

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources